Since 2004, the MRF has funded basic research that has led to the publication of more than 80 peer-reviewed scientific articles, the identification of more than 150 novel potential myelin repair treatment targets and the discovery of 24 new research tools—animal models and assays—that may help to accelerate research on all neurological diseases. Two patents have been awarded on this work. The MRF is supported by the generous gifts of individuals, foundations and corporations. Since 2004, we have raised $45 million to support our myelin repair research program.
The MRF Model: Revolutionizing All Medical Research
The MRF is demonstrating on myelin repair for MS, a new and comprehensive model for medical research and drug development that significantly shortens the time to market for new medicines for all diseases. By recognizing the incentives and limitations of academic scientists, commercial biopharma and government regulators, the Accelerated Research Collaboration ™ (ARC™) Model provides a clear pathway from bench to bedside by leveraging the MRF's position as a non-partisan, non-profit organization with only one goal in mind: shortening the time to market for new medicines for patients who can't afford to wait.Learn more about our Principal Investigators, Scientific Advisory Board, and Drug Discovery Advisory Board.
No comments:
Post a Comment